Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

COCA.xyz, the next-generation non-custodial payments app, has successfully completed a strategic funding round led by the Stellar Development Foundation (SDF), with participation from FunFair Ventures ...

At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...

Investor Day to be held in New York on March 19 at 9 am. Webcast LinkLight Up your Portfolio with Spark:Easily identify stocks' risks and ...

Both companies have a history of developing treatments for various medical needs, with Entera focusing on oral peptide and protein replacement therapies and OPKO on leveraging its proprietary ...

A Call for Global Collaboration “Ocean Quest International is eager to engage with forward-thinking investors and partners who share our vision for a sustainable future,” added Roider.

“We’d be able to check your health through a bunch of diagnostics, allow you to set your health goals and your budgets ... Tastemade previously raised $130 million from investors, closing its most ...